The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of ICI sensitivity for pembrolizumab in combination with anti-platelet therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (HNSCC).
 
Karthik Chakravarthy
No Relationships to Disclose
 
John M. Kaczmar
Stock and Other Ownership Interests - HCA Healthcare (I)
Honoraria - The Scienomics Group; Triangle Insights Group
Consulting or Advisory Role - Bicara Therapeutics; Coherus Biosciences; Rakuten Medical
 
Brian Riesenberg
No Relationships to Disclose
 
Carolyn D. Britten
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Patent pending for treatment of squamous NSCLC. (Inst)
Travel, Accommodations, Expenses - Amgen
 
Alan Brisendine
No Relationships to Disclose
 
Elizabeth Goodwin Hill
No Relationships to Disclose
 
Bei Liu
No Relationships to Disclose
 
Zihai Li
Stock and Other Ownership Interests - Agenus (I); yuMed
Honoraria - Alphamab; Heat Biologics; Henlius
Consulting or Advisory Role - Abbvie; Alphamab; HANCHORBIO; Heat Biologics; Henlius; Ikonisys
Research Funding - Bristol-Myers Squibb; Heat Biologics
Patents, Royalties, Other Intellectual Property - Have a patent on HSP vaccine technology that was license to Agenus